
ABBOTT LABORATORIES — Investor Relations & Filings
Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | |
| 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | |
| 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36260641 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | ||
| 34661940 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | ||
| 34647007 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | ||
| 33051650 | SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | ||
| 33043414 | 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33043382 | 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33016698 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 33013457 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 32874359 | 4 Filing | 2026-03-04 | English | ||
| 32874360 | 4 Filing | 2026-03-04 | English | ||
| 32874361 | 4 Filing | 2026-03-04 | English | ||
| 32874362 | 4 Filing | 2026-03-04 | English | ||
| 32874363 | 4 Filing | 2026-03-04 | English | ||
| 32874364 | 4 Filing | 2026-03-04 | English | ||
| 32874365 | 4 Filing | 2026-03-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Innovations Inc.
Develops, manufactures, and sells science-based natural hea…
|
ATB | CA | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
|
Aurinia Pharmaceuticals Inc.
Biopharmaceutical company developing therapies for severe a…
|
AUPH | US | Manufacturing |
|
Aurisco Pharmaceutical Co.,Ltd.
Develops and manufactures complex APIs and intermediates wi…
|
605116 | CN | Manufacturing |
|
Aurobindo Pharma Ltd.
Vertically integrated developer and manufacturer of generic…
|
AUROPHARMA | IN | Manufacturing |
|
Auro Laboratories Ltd.
Manufactures WHO-GMP compliant APIs and intermediates, spec…
|
530233 | IN | Manufacturing |
|
Aurora Cannabis Inc.
Global producer and distributor of cannabis products for me…
|
ACB | CA | Manufacturing |
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | US | Manufacturing |
ABBOTT LABORATORIES via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29777/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29777 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29777 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29777 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29777}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABBOTT LABORATORIES (id: 29777)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.